Dr Steven Sbardella, MD | |
585 Lebanon St, Melrose, MA 02176-3225 | |
(781) 937-4522 | |
Not Available |
Full Name | Dr Steven Sbardella |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 585 Lebanon St, Melrose, Massachusetts |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275594400 | NPI | - | NPPES |
3018687 | Medicaid | MA | |
J06600 | Other | MA | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 56638 (Massachusetts) | Primary |
Entity Name | Melrose Wakefield Emergency Physicians, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790730539 PECOS PAC ID: 0244143006 Enrollment ID: O20031107000277 |
News Archive
Cornell biomedical engineers have discovered a new way to destroy metastasizing cancer cells traveling through the bloodstream - lethal invaders that are linked to almost all cancer deaths - by hitching cancer-killing proteins along for a ride on life-saving white blood cells.
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group.
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
Pathway Therapeutics, a drug discovery and development company founded in New Zealand, announced that it has met an important drug development milestone triggering a US$4.5 million fourth tranche of its Series A private equity placement. The financing was led by GBS Venture Partners, Australia and CM Capital Investments, Australia with co-investors the Breast Cancer Research Trust, the Trans-Tasman Commercialisation Fund, and the New Zealand Venture Investment Firm.
› Verified 4 days ago
Entity Name | Hallmark Health Urgent Care Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184066912 PECOS PAC ID: 1153557616 Enrollment ID: O20131112001050 |
News Archive
Cornell biomedical engineers have discovered a new way to destroy metastasizing cancer cells traveling through the bloodstream - lethal invaders that are linked to almost all cancer deaths - by hitching cancer-killing proteins along for a ride on life-saving white blood cells.
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group.
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
Pathway Therapeutics, a drug discovery and development company founded in New Zealand, announced that it has met an important drug development milestone triggering a US$4.5 million fourth tranche of its Series A private equity placement. The financing was led by GBS Venture Partners, Australia and CM Capital Investments, Australia with co-investors the Breast Cancer Research Trust, the Trans-Tasman Commercialisation Fund, and the New Zealand Venture Investment Firm.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Steven Sbardella, MD 258 Independence Rd, Concord, MA 01742-2645 Ph: (978) 287-5969 | Dr Steven Sbardella, MD 585 Lebanon St, Melrose, MA 02176-3225 Ph: (781) 937-4522 |
News Archive
Cornell biomedical engineers have discovered a new way to destroy metastasizing cancer cells traveling through the bloodstream - lethal invaders that are linked to almost all cancer deaths - by hitching cancer-killing proteins along for a ride on life-saving white blood cells.
As antibiotic-resistant bacteria become more urgent threats worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will provide up to $102.5 million in renewed funding over seven years for the Antibacterial Resistance Leadership Group.
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
Pathway Therapeutics, a drug discovery and development company founded in New Zealand, announced that it has met an important drug development milestone triggering a US$4.5 million fourth tranche of its Series A private equity placement. The financing was led by GBS Venture Partners, Australia and CM Capital Investments, Australia with co-investors the Breast Cancer Research Trust, the Trans-Tasman Commercialisation Fund, and the New Zealand Venture Investment Firm.
› Verified 4 days ago
Alexander O. Walker Iii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3635 | |
Thomas L Michelman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Whidden Memorial Hosp, Melrose, MA 02176 Phone: 781-979-3300 | |
Christopher L Defazio, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3635 Fax: 781-979-3018 | |
Lawrence Whiting, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-937-4522 | |
Garett Burke, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-979-3300 | |
John Nadolny, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 585 Lebanon St, Melrose, MA 02176 Phone: 781-937-4522 |